
Celebrating the Opening of Genovn Therapeutics! ✨
We are excited to witness the official opening of Genovn Therapeutics, a pioneering biotech company dedicated to advancing cutting-edge NK cell therapies for cancer treatment.
A big thank you to Jonathan Loh, Qi-Jing Li, and Li-Feng Zhang for making this possible. This milestone marks the beginning of an inspiring journey, and we truly hope this technology will help patients in the near future.
Congratulations to the Genovn team on this important achievement — we look forward to the breakthroughs ahead! 🚀🧬